{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T11:40:44Z","timestamp":1774352444962,"version":"3.50.1"},"reference-count":40,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T00:00:00Z","timestamp":1708041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Korea National Institute of Health, Korea Disease Control and Prevention Agency","award":["2022-NI-050-01"],"award-info":[{"award-number":["2022-NI-050-01"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>During the emergence of infectious diseases, evaluating the efficacy of newly developed vaccines requires antigen proteins. Available methods enhance antigen protein productivity; however, structural modifications may occur. Therefore, we aimed to construct a novel transient overexpression vector capable of rapidly producing large quantities of antigenic proteins in mammalian cell lines. This involved expanding beyond the exclusive use of the human cytomegalovirus (CMV) promoter, and was achieved by incorporating a transcriptional enhancer (CMV enhancer), a translational enhancer (woodchuck hepatitis virus post-transcriptional regulatory element), and a promoter based on the CMV promoter. Twenty novel transient expression vectors were constructed, with the vector containing the human elongation factor 1-alpha (EF-1a) promoter showing the highest efficiency in expressing foreign proteins. This vector exhibited an approximately 27-fold higher expression of enhanced green fluorescent protein than the control vector containing only the CMV promoter. It also expressed the highest level of severe acute respiratory syndrome coronavirus 2 receptor-binding domain protein. These observations possibly result from the simultaneous enhancement of the transcriptional activity of the CMV promoter and the human EF-1a promoter by the CMV enhancer. Additionally, the synergistic effect between the CMV and human EF-1a promoters likely contributed to the further enhancement of protein expression.<\/jats:p>","DOI":"10.3390\/ijms25042330","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T03:37:27Z","timestamp":1708054647000},"page":"2330","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Novel Enhanced Mammalian Cell Transient Expression Vector via Promoter Combination"],"prefix":"10.3390","volume":"25","author":[{"given":"SunKyung","family":"Yoon","sequence":"first","affiliation":[{"name":"Division of Clinical Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28160, Chungcheongbuk-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SeJin","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Clinical Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28160, Chungcheongbuk-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JuneWoo","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Clinical Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28160, Chungcheongbuk-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byoungguk","family":"Kim","sequence":"additional","affiliation":[{"name":"Division of Clinical Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28160, Chungcheongbuk-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1956-8216","authenticated-orcid":false,"given":"WonSeok","family":"Gwak","sequence":"additional","affiliation":[{"name":"Division of Clinical Vaccine Research, Center for Vaccine Research, National Institute of Infectious Diseases, National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju 28160, Chungcheongbuk-do, Republic of Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,2,16]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12934-017-0654-4","article-title":"Trends in recombinant protein use in animal production","volume":"16","author":"Gifre","year":"2017","journal-title":"Microb. Cell Factories"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","article-title":"Vaccine development for emerging infectious diseases","volume":"27","author":"Excler","year":"2021","journal-title":"Nat. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/d41586-020-03626-1","article-title":"The lightning-fast quest for COVID vaccines\u2014And what it means for other diseases","volume":"589","author":"Ball","year":"2021","journal-title":"Nature"},{"key":"ref_4","unstructured":"Balawejder, F., Sampson, S., and Stratton, T. (2024, February 12). Industrial Strategy Council Home Page. Available online: https:\/\/industrialstrategycouncil.org\/lessons-industrial-policy-development-oxfordastrazeneca-covid-19-vaccine."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1068449","DOI":"10.3389\/fimmu.2022.1068449","article-title":"Protein post-translational modification in SARS-CoV-2 and host interaction","volume":"13","author":"Cheng","year":"2022","journal-title":"Front. Immunol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5358272","DOI":"10.1155\/2016\/5358272","article-title":"Posttranslational modifications and the immunogenicity of biotherapeutics","volume":"2016","author":"Jefferis","year":"2016","journal-title":"J. Immunol. Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.sbi.2008.07.001","article-title":"Overcoming the challenges of membrane protein crystallography","volume":"18","author":"Carpenter","year":"2008","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"M111.007930","DOI":"10.1074\/mcp.M111.007930","article-title":"Physiological response to membrane protein overexpression in E. coli","volume":"10","author":"Gubellini","year":"2011","journal-title":"Mol. Cell. Proteom."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.jmb.2011.02.007","article-title":"Consequences of the overexpression of a eukaryotic membrane protein, the human KDEL receptor, in Escherichia coli","volume":"407","author":"Klepsch","year":"2011","journal-title":"J. Mol. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1074\/mcp.M600431-MCP200","article-title":"Consequences of membrane protein overexpression in Escherichia coli","volume":"6","author":"Wagner","year":"2007","journal-title":"Mol. Cell. Proteom."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-352-3_1","article-title":"Why proteins in mammalian cells","volume":"801","author":"Hartley","year":"2012","journal-title":"Methods Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/btpr.1842","article-title":"Protein production using the baculovirus-insect cell expression system","volume":"30","author":"Chisti","year":"2014","journal-title":"Biotechnol. Prog."},{"key":"ref_13","first-page":"71","article-title":"Glycobiotechnology of the insect cell-baculovirus expression system technology","volume":"175","author":"Palomares","year":"2021","journal-title":"Adv. Biochem. Eng. Biotechnol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/bmb.20301","article-title":"Biotechnology: Applying the genetic revolution by David P. Clark and Nanette J. Pazdernik","volume":"37","author":"Schuster","year":"2009","journal-title":"Biochem. Mol. Biol. Educ."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jsb.2010.02.006","article-title":"Recent advances in the production of proteins in insect and mammalian cells for structural biology","volume":"172","author":"Nettleship","year":"2010","journal-title":"J. Struct. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jbiotec.2006.07.012","article-title":"Select what you need: A comparative evaluation of the advantages and limitations of frequently used expression systems for foreign genes","volume":"127","author":"Yin","year":"2007","journal-title":"J. Biotechnol."},{"key":"ref_17","first-page":"257","article-title":"Gene expression in mammalian cells and its applications","volume":"3","author":"Khan","year":"2013","journal-title":"Adv. Pharm. Bull."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/pro.307","article-title":"Fusion partners can increase the expression of recombinant interleukins via transient transfection in 2936E cells","volume":"19","author":"Carter","year":"2010","journal-title":"Protein Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12934-018-0901-3","article-title":"Signal peptides for recombinant protein secretion in bacterial expression systems","volume":"17","author":"Freudl","year":"2018","journal-title":"Microb. Cell Fact."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s10529-011-0533-8","article-title":"Self-cleaving fusion tags for recombinant protein production","volume":"33","author":"Li","year":"2011","journal-title":"Biotechnol. Lett."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.aspen.2018.08.003","article-title":"Increased productivity of the baculovirus expression vector system by combining enhancing factors","volume":"21","author":"Lee","year":"2018","journal-title":"J. Asia Pac. Entomol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jbiotec.2020.02.015","article-title":"Construction and application of a dual promoter system for efficient protein production and metabolic pathway enhancement in Bacillus licheniformis","volume":"312","author":"Rao","year":"2020","journal-title":"J. Biotechnol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"7459","DOI":"10.1007\/s00253-017-8487-y","article-title":"Double promoter expression systems for recombinant protein production by industrial microorganisms","volume":"101","year":"2017","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejps.2018.08.016","article-title":"Enhanced transgene expression using cis-acting elements combined with the EF1 promoter in a mammalian expression system","volume":"123","author":"Wang","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1128\/JVI.73.4.2886-2892.1999","article-title":"Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors","volume":"73","author":"Zufferey","year":"1999","journal-title":"J. Virol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1089\/10430349950016942","article-title":"Enhanced expression of transgenes from adeno-associated virus vectors with the woodchuck hepatitis virus posttranscriptional regulatory element: Implications for gene therapy","volume":"10","author":"Loeb","year":"1999","journal-title":"Hum. Gene Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/sj.embor.7400390","article-title":"Woodchuck post-transcriptional element induces nuclear export of myotonic dystrophy 3\u2032 untranslated region transcripts","volume":"6","author":"Mastroyiannopoulos","year":"2005","journal-title":"EMBO Rep."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.gene.2005.12.018","article-title":"WPRE-mediated enhancement of gene expression is promoter and cell line specific","volume":"372","author":"Klein","year":"2006","journal-title":"Gene"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1038\/sj.gt.3302309","article-title":"Self-inactivating retroviral vectors with improved RNA processing","volume":"11","author":"Kraunus","year":"2004","journal-title":"Gene Ther."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.1128\/JVI.77.16.8801-8811.2003","article-title":"The coronavirus spike protein is a class I virus fusion protein: Structural and functional characterization of the fusion core complex","volume":"77","author":"Bosch","year":"2003","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Errasti-Murugarren, E., Bartoccioni, P., and Palac\u00edn, M. (2021). Membrane protein stabilization strategies for structural and functional studies. Membranes, 11.","DOI":"10.3390\/membranes11020155"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"100497","DOI":"10.1016\/j.xpro.2021.100497","article-title":"Protocol for cell preparation and gene delivery in HEK293T and C2C12 cells","volume":"2","author":"Jiang","year":"2021","journal-title":"Star Protoc."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pep.2005.07.008","article-title":"High levels of protein expression using different mammalian CMV promoters in several cell lines","volume":"45","author":"Xia","year":"2006","journal-title":"Protein Expr. Purif."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Alexopoulou, A.N., Couchman, J.R., and Whiteford, J.R. (2008). The CMV early enhancer\/chicken \u03b2 actin (CAG) promoter can be used to drive transgene expression during the differentiation of murine embryonic stem cells into vascular progenitors. BMC Cell Biol., 9.","DOI":"10.1186\/1471-2121-9-2"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1111\/jcmm.13216","article-title":"The EF-1\u03b1 promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells","volume":"21","author":"Wang","year":"2017","journal-title":"J. Cell. Mol. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/mrd.20983","article-title":"Stable transgene expression in human embryonic stem cells after simple chemical transfection","volume":"76","author":"Liu","year":"2009","journal-title":"Mol. Reprod. Dev."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1006\/mthe.2000.0190","article-title":"Lentiviral vectors for enhanced gene expression in human hematopoietic cells","volume":"2","author":"Ramezani","year":"2000","journal-title":"Mol. Ther."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Norrman, K., Fischer, Y., Bonnamy, B., Wolfhagen, S.F., Ravassard, P., and Semb, H. (2010). Quantitative comparison of constitutive promoters in human ES cells. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0012413"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1128\/JVI.77.6.3602-3614.2003","article-title":"The human cytomegalovirus major immediate-early enhancer determines the efficiency of immediate-early gene transcription and viral replication in permissive cells at low multiplicity of infection","volume":"77","author":"Isomura","year":"2003","journal-title":"J. Virol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/4\/2330\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:00:27Z","timestamp":1760104827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/25\/4\/2330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,16]]},"references-count":40,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["ijms25042330"],"URL":"https:\/\/doi.org\/10.3390\/ijms25042330","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,16]]}}}